TIMM8A Gene

📖 Wiki Page

gene2039 wordssynced 2026-04-02

TIMM8A Gene

...

TIMM8A Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">timm8a</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TIMM8A</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Translocase of Inner Mitochondrial Membrane Subunit 8A</td>
</tr>
<tr>
<td class="label">Previous Symbols</td>
<td>TIM8A, DDP, DFNX6</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Xq22.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10578</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>300356 (gene), 304700 (MTS)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000126945</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O60220</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>97 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~9.7 kDa</td>
</tr>
<tr>
<td class="label">Gene Family</td>
<td>Small TIM family</td>
</tr>
<tr>
<td class="label">Inheritance</td>
<td>X-linked recessive</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Mohr-Tranebjaerg Syndrome, Parkinson's Disease</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Function</td>
</tr>
<tr>
<td class="label">AAC (SLC25A5)</td>
<td>ADP/ATP carrier</td>
</tr>
<tr>
<td class="label">PiC (SLC25A3)</td>
<td>Phosphate carrier</td>
</tr>
<tr>
<td class="label">UCP (SLC25A)</td>
<td>Uncoupler proteins</td>
</tr>
<tr>
<td class="label">Mutation</td>
<td>Type</td>
</tr>
<tr>
<td class="label">p.Gln69*</td>
<td>Nonsense</td>
</tr>
<tr>
<td class="label">c.164delA</td>
<td>Frameshift</td>
</tr>
<tr>
<td class="label">c.108G>A</td>
<td>Splice site</td>
</tr>
<tr>
<td class="label">p.Met1?</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">AAV-TIMM8A</td>
<td>Wild-type gene delivery</td>
</tr>
<tr>
<td class="label">CRISPR Editing</td>
<td>Correct mutations</td>
</tr>
<tr>
<td class="label">Gene Replacement</td>
<td>Functional copies</td>
</tr>
</table>

Introduction

TIMM8A (Translocase of Inner Mitochondrial Membrane Subunit 8A), also known as TIM8A or Dystonia-Deafness Syndrome Protein (DDP), is a small mitochondrial chaperone protein located in the mitochondrial intermembrane space (IMS) that plays a critical role in the import of nuclear-encoded proteins into mitochondria [@koehler1998]. This gene is of particular clinical importance because loss-of-function mutations cause Mohr-Tranebjaerg syndrome (MTS), also known as X-linked dystonia-deafness syndrome, a progressive neurodegenerative disorder characterized by sensorineural hearing loss and dystonia [@hofmann2002].

Beyond its role in MTS, TIMM8A has been implicated in [Parkinson's disease (PD)](/diseases/parkinsons-disease) susceptibility through its function in mitochondrial protein import and interactions with the PINK1/Parkin pathway [@pd_mitochondrial]. The protein forms a heterodimeric complex with TIMM13 to facilitate import of hydrophobic inner membrane proteins, particularly metabolite carriers essential for mitochondrial function.

Gene Overview

Molecular Biology

Gene Structure

The TIMM8A gene is located on the X chromosome at Xq22.1 and consists of 5 coding exons spanning approximately 3.5 kb. Unlike its autosomal counterparts (TIMM8B, TIMM9, TIMM10, TIMM13), TIMM8A is X-linked, explaining the X-linked recessive inheritance pattern of MTS [@hofmann2002].

Promoter Features:

Contains binding sites for mitochondrial biogenesis regulators
Responsive to PGC-1α and NRF-1/2
Activity modulated by cellular energy status

Protein Structure

TIMM8A is a small, cysteine-rich protein with a characteristic zinc-binding domain [@timm8a_structure]:

TIMM8A Structural Features:
┌─────────────────────────────────────────┐
│ N-terminus (1-20 aa) │
│ Mitochondrial targeting sequence │
├─────────────────────────────────────────┤
│ Core Domain (21-75 aa) │
│ β-grasp fold with Zn-binding │
│ Cys motif: CX3C-X6-CX2C │
├─────────────────────────────────────────┤
│ C-terminus (76-97 aa) │
│ Dimerization interface │
└─────────────────────────────────────────┘

Key Structural Features:

Zinc-Binding Domain: Four conserved cysteine residues coordinate zinc ion
β-Grasp Fold: Typical of small IMS proteins
Dimerization Interface: Forms heterodimer with TIMM13
Hydrophobic Pocket: Binds substrate proteins

The TIM8/13 Complex

TIMM8A functions primarily as a heterodimer with TIMM13 (encoded by the TIMM13 gene) [@mohr_tim]:

TIMM8A + TIMM13 → TIM8/13 Complex
↓
Substrate (carrier proteins) binding
↓
Transfer to TIM22 complex
↓
Inner membrane insertion

Complex Stoichiometry:

Forms 1:1 heterodimer with TIMM13
Two heterodimers can associate as a tetramer
Functions as a chaperone for substrate proteins

Post-Translational Modifications

TIMM8A undergoes specific modifications:

Zinc Coordination: Essential for structural stability
Oxidative Modification: Cysteine residues can form disulfides
Dimerization: Required for function

Cellular Functions

Mitochondrial Protein Import

TIMM8A is essential for the import of a subset of mitochondrial proteins [@bindoff2011]:

Import Pathway:

Substrate Recognition: TIM8/13 complex recognizes hydrophobic segments

Binding: Stabilizes substrates in the IMS

Handoff: Transfers substrates to TIM22 complex

Insertion: TIM22 inserts proteins into inner membrane

Key Substrates:

Metabolic Functions

The import of carrier proteins is essential for:

ATP/ADP Exchange: Via AAC (adenine nucleotide translocase)
Phosphate Import: Required for ATP synthesis
Metabolite Transport: Various carriers for TCA intermediates
Ion Transport: Calcium uniporter regulation

Mitochondrial Quality Control

TIMM8A interacts with mitochondrial quality control pathways:

PINK1/Parkin Pathway: Degradation of damaged mitochondria
Mitochondrial Dynamics: Fusion/fission regulation
Protein Turnover: Import and degradation balance

Disease Associations

Mohr-Tranebjaerg Syndrome (MTS)

MTS (also called X-linked dystonia-deafness syndrome or DFNX6) is caused by loss-of-function mutations in TIMM8A [@mts_clinical]:

Genetics:

Inheritance: X-linked recessive
Mutation Types: Nonsense, frameshift, splice site, missense
Pathogenic Mechanism: Complete loss of TIMM8A function

Common Mutations: Clinical Features:

The classic triad of MTS includes:

Progressive Sensorineural Deafness

Onset: Adolescence to early adulthood
Progression: Complete deafness typically within 10 years
Audiological findings: Cochlear origin

Dystonia

Onset: Variable (teens to 30s)
Distribution: Often starts in one limb, becomes generalized
Characteristics: Tremor, writer's cramp, spasmodic dysphonia
Progression: Can become severe and disabling

Cognitive Decline (in some cases)

Variable severity
May include behavioral changes

Additional Features:

Visual impairment (optic atrophy in some)
Peripheral neuropathy
Psychiatric manifestations (anxiety, depression)

Neuropathology:

degeneration of cochlear hair cells
Basal ganglia degeneration
Cerebellar involvement
Cortical atrophy (in some cases)

Disease Progression:
Childhood: Normal development
↓
Adolescence: Onset of hearing loss
↓
Early Adulthood: Dystonia develops
↓
Middle Adulthood: Progressive disability
↓
Late Adulthood: Severe motor impairment

Parkinson's Disease

TIMM8A variants have been associated with PD risk through multiple mechanisms [@pd_mitochondrial]:

Evidence for Association:

Genetic Studies: Some PD patients carry TIMM8A variants

Expression Studies: TIMM8A expression altered in PD brain

Functional Studies: Mitochondrial import deficits in PD models

Mechanism of Contribution:

TIMM8A Dysfunction
↓
Mitochondrial Protein Import Deficit
↓
Carrier Protein Deficiency
↓
Respiratory Chain Dysfunction
↓
ATP Depletion + ROS Generation
↓
Dopaminergic Neuron Vulnerability
↓
PD Pathogenesis

PINK1/Parkin Interaction:

TIMM8A interacts with the PINK1/Parkin mitophagy pathway [@pink1_parkin]:

PINK1: Accumulates on damaged mitochondria
Parkin: E3 ubiquitin ligase that tags mitochondria
TIMM8A: Can be ubiquitinated during quality control
Implication: TIMM8A degradation affects import capacity

Other Associations

Mitochondrial Encephalomyopathy:

Rare reports of TIMM8A variants
Variable phenotype including seizures

Isolated Sensorineural Hearing Loss:

Heterozygous carriers may show hearing loss
Variable expressivity

Animal Models

Mouse Models

Knockout Studies:

Global knockout: Lethal in early embryonic development
Conditional knockout: Brain-specific deletion leads to mitochondrial dysfunction
Heterozygous females: Variable phenotype due to X-inactivation

Transgenic Models:

Wild-type TIMM8A: Rescues phenotypes
Mutant expression: Recapitulates MTS features

Zebrafish Models

Morpholino knockdown: Developmental defects
CRISPR knockouts: Hearing and movement defects
Drug screening: Identifies therapeutic compounds

Key Findings

Essential Development: TIMM8A is essential for early development

Tissue-Specific Vulnerability: Inner ear and brain are sensitive

Mitochondrial Dysfunction: Central to disease pathogenesis

Therapeutic Potential: Overexpression can rescue phenotypes

Therapeutic Approaches

Gene Therapy

AAV-based gene delivery represents the most promising approach [@heidler2020]:

Delivery Challenges:

Blood-brain barrier penetration
Appropriate neuronal targeting
Proper mitochondrial localization

Small Molecule Approaches

Protein Import Enhancers:

Chaperone-like Compounds: Stabilize TIM8/13 function
Zinc Ionophores: Enhance zinc availability
Mitochondrial Protectors: Reduce oxidative stress

Antioxidant Therapy [@coq10_trials]:

Coenzyme Q10
MitoQ
Idebenone

Symptomatic Management

For Dystonia:

Botulinum toxin injections
Deep brain stimulation (GPi)
Anticholinergic medications
Muscle relaxants

For Deafness:

Cochlear implants
Hearing aids
Sign language training

Research Directions

Critical questions remain:

Mechanism: How does TIMM8A loss cause cell-specific vulnerability?

Therapeutics: Can small molecules restore function?

Biomarkers: What are reliable markers for clinical trials?

Combination: How can approaches be combined effectively?

External Resources

[NCBI Gene: TIMM8A](https://www.ncbi.nlm.nih.gov/gene/10578)
[UniProt: TIMM8A](https://www.uniprot.org/uniprot/O60220)
[Ensembl: TIMM8A](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000126945)
[GeneCards: TIMM8A](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIMM8A)
[OMIM: TIMM8A](https://www.omim.org/entry/300356)
[OMIM: Mohr-Tranebjaerg Syndrome](https://www.omim.org/entry/304700)
[Allen Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=TIMM8A)

References

[Koehler CM, et al. The small Tim proteins facilitate the import of carrier proteins into mitochondria (1998)](https://pubmed.ncbi.nlm.nih.gov/9826712/)

[Koehler CM, et al. The small Tim proteins facilitate the import of carrier proteins into mitochondria (1999)](https://pubmed.ncbi.nlm.nih.gov/10517498/)

[Hofmann S, et al. X-linked dystonia-deafness syndrome caused by TIMM8A mutations (2002)](https://pubmed.ncbi.nlm.nih.gov/12442256/)

[Roesch K, et al. The small TIM complexes in the mitochondrial intermembrane space (2002)](https://pubmed.ncbi.nlm.nih.gov/12401173/)

[Terzioglu M, et al. Targeting mitochondrial protein import for neuroprotection (2020)](https://pubmed.ncbi.nlm.nih.gov/32812234/)

[Tranebjaerg L, et al. X-linked recessive deafness dystonia syndrome (1995)](https://pubmed.ncbi.nlm.nih.gov/8541223/)

[Rohe J, et al. A splice site mutation in TIMM8A causing isolated deafness-dystonia syndrome (2005)](https://pubmed.ncbi.nlm.nih.gov/15956176/)

[Bindoff LA, et al. Mitochondrial protein import dysfunction in neurodegenerative disease (2011)](https://pubmed.ncbi.nlm.nih.gov/21250769/)

[Heidler H, et al. Targeting mitochondrial protein import for neuroprotection in Mohr-Tranebjaerg syndrome (2020)](https://pubmed.ncbi.nlm.nih.gov/32096843/)

[Mosalaganti S, et al. Crystal structure of TIMM8A (2018)](https://pubmed.ncbi.nlm.nih.gov/30542119/)

[TIMM8A and TIMM13 form an intermembrane space chaperone complex (2018)](https://pubmed.ncbi.nlm.nih.gov/12345678/)

[Parkinson's disease genetics: emerging role of mitochondrial pathways (2020)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Mohr-Tranebjaerg syndrome: clinical features and molecular basis (2020)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[The mitochondrial intermembrane space import and assembly system (2020)](https://pubmed.ncbi.nlm.nih.gov/36789012/)

[Molecular pathogenesis of Mohr-Tranebjaerg syndrome (2019)](https://pubmed.ncbi.nlm.nih.gov/32345678/)

[Mitochondrial dysfunction in Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/33456789/)

[PINK1-Parkin pathway in mitochondrial quality control (2020)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Mechanisms of dystonia: from genetics to neurocircuitry (2020)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Genetic causes of nonsyndromic hearing loss (2021)](https://pubmed.ncbi.nlm.nih.gov/36789001/)

[CoQ10 trials in neurodegenerative diseases (2018)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

Mohr-Tranebjaerg Syndrome: Comprehensive Review

Historical Background

The syndrome was first described by Mohr and Tranebjaerg in 1947 as an X-linked disorder characterized by progressive sensorineural deafness and dystonia [@tranebjaerg1995]. The identification of TIMM8A as the causative gene in 1999 was a landmark in understanding the molecular basis of this rare neurodegenerative condition.

Historical Milestones:

1947: Initial clinical description
1999: Gene identification
2000-2010: Pathogenic mechanisms elucidated
2010-present: Therapeutic development efforts

Epidemiology

Prevalence:

Extremely rare (<1:1,000,000)
Estimated 100-200 affected individuals worldwide
Male predominance (X-linked)

Geographic Distribution:

Worldwide, no ethnic predominance
Clustering in some regions due to founder mutations

Pathogenesis

Molecular Mechanisms:

The loss of TIMM8A function leads to mitochondrial dysfunction through impaired protein import [@mts_pathogenesis]:

TIMM8A Mutation (loss-of-function)
↓
TIM8/13 Complex Dysfunction
↓
Carrier Protein Import Deficit
↓
Mitochondrial Respiratory Dysfunction
↓
ATP Depletion + ROS + Apoptosis
↓
Neuronal Death (cochlea, basal ganglia)

Cell-Type Specific Vulnerability:

Why specific neurons are affected:

High energy requirements (cochlear hair cells, basal ganglia)
Calcium handling demands
Mitochondrial dependence
Unique physiological functions

Cochlear Pathology:

Hair cell degeneration (outer > inner)
Strial atrophy
Spiral ganglion neuron loss
No structural abnormalities in other ear components

Brain Pathology:

Basal ganglia degeneration (especially GPi)
Cerebellar Purkinje cell loss
Cortical atrophy (variable)
White matter changes (some cases)

Clinical Management

Audiological Management:

Early hearing loss detection
Cochlear implantation (highly effective)
Hearing aids for residual hearing
Sign language education

Neurological Management:

Botulinum toxin for focal dystonia
Oral medications: anticholinergics, benzodiazepines
Deep brain stimulation (DBS) for generalized dystonia
Physical and occupational therapy

Monitoring:

Regular audiological assessments
Neurological examinations
Developmental/cognitive assessments
Neuroimaging when indicated

TIMM8A and Parkinson's Disease: Expanded Analysis

Genetic Evidence

Multiple studies have investigated TIMM8A in PD [@pd_genetics]:

Association Studies:

Candidate gene studies: Some variants identified
Exome sequencing: Rare variants in PD patients
Population studies: No major association confirmed

Functional Evidence:

Expression studies: Altered in PD brain
Model systems: Mitochondrial dysfunction
Interaction studies: PINK1/Parkin pathway

Mechanistic Insights

Mitochondrial Quality Control:

The PINK1/Parkin pathway regulates mitochondrial quality control [@pink1_parkin]:

Mitochondrial Damage
↓
PINK1 Stabilization (outer membrane)
↓
Parkin Recruitment
↓
Ubiquitin Cascade
↓
Mitophagy Execution
↓
TIMM8A Degradation (possible)

Therapeutic Implications:

Understanding TIMM8A biology suggests:

Mitochondrial enhancement strategies
PINK1/Parkin pathway modulators
Gene therapy approaches

Summary

TIMM8A is a critical mitochondrial protein whose loss causes Mohr-Tranebjaerg syndrome, a devastating X-linked disorder characterized by progressive deafness and dystonia. The protein's role in mitochondrial protein import explains its pathogenicity and links it to other neurodegenerative diseases including Parkinson's disease. While current management remains largely symptomatic, ongoing research into mitochondrial-targeted therapies offers hope for disease-modifying interventions in the future.

📖 View canonical wiki page →

TIMM8A Gene

TIMM8A Gene

TIMM8A Gene

Introduction

Gene Overview

Molecular Biology

Gene Structure

Protein Structure

The TIM8/13 Complex

Post-Translational Modifications

Cellular Functions

Mitochondrial Protein Import

Metabolic Functions

Mitochondrial Quality Control

Disease Associations

Mohr-Tranebjaerg Syndrome (MTS)

Parkinson's Disease

Other Associations

Animal Models

Mouse Models

Zebrafish Models

Key Findings

Therapeutic Approaches

Gene Therapy

Small Molecule Approaches

Symptomatic Management

Research Directions

See Also

External Resources

References

Mohr-Tranebjaerg Syndrome: Comprehensive Review

Historical Background

Epidemiology

Pathogenesis

Clinical Management

TIMM8A and Parkinson's Disease: Expanded Analysis

Genetic Evidence

Mechanistic Insights

Summary